Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.00
Bid: 88.00
Ask: 92.00
Change: 1.00 (1.12%)
Spread: 4.00 (4.545%)
Open: 89.00
High: 90.00
Low: 86.20
Prev. Close: 89.00
NET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Skore Labs Limited

23 Jan 2024 07:01

RNS Number : 5259A
Netcall PLC
23 January 2024
 

23 January 2024

 

NETCALL PLC 

("Netcall", the "Company" or the "Group") 

Acquisition of Skore Labs Limited

Enhancing the Liberty digital transformation platform, increasing market opportunity and cross-sale potential

Netcall plc (AIM: NET), a leading provider of intelligent automation and customer engagement software, is pleased to announce the acquisition of Skore Labs Limited ("Skore"), a cloud-based process improvement software company (the "Acquisition").

Key points:

·

Highly complementary bolt-on solution, enhancing and broadening Netcall's offering as a one-stop-shop digital transformation toolkit

·

Provides increased cross-selling potential and expanded market opportunity and reach

·

Brings new customers across industries and a compatible cloud recurring revenue model

·

Initial consideration of £2 million, with additional earnout resulting in a maximum consideration of up to £6.225 million

About Skore

Skore (www.getskore.com) is a UK company that provides a cloud-based software solution for business process discovery, mapping, analysis and management. As an intuitive and collaborative solution, users can rapidly identify process problems as well as opportunities for optimisation to drive operational improvement, innovation and efficiencies.

Based in Portsmouth, Skore was established in 2014 and has c.120 customers across a range of industries, including Ashford Borough Council, Cielo, Holland & Barrett, Northrop Grumman and University College London NHS Trust. All of the current team will remain with the Netcall group.

For the year ended 31 December 2023, Skore's revenues have grown 96% to £449k (2022: £229k) with an adjusted EBITDA loss of £55k (2022: loss of £159k) (figures from unaudited managements accounts). Annual recurring revenue (ARR) from cloud subscriptions increased by 179% to £651k (2022: £233k).

Acquisition Rationale

Process mapping is a foundation capability that enhances Netcall's current product portfolio. With the expanded Liberty platform that incorporates Skore's process mapping solution with Liberty's low-code, robotic process automation and AI solutions, customers will be able to build solutions, streamline and automate processes faster and easier, to improve operational effectiveness and efficiency.

The expanded Liberty platform also allows Netcall customers to add process mapping to their subscriptions, creating cross-selling potential and new customer opportunities for organisations that want a comprehensive all-in-one process solution.

Consideration for the Acquisition

The total consideration for the Acquisition, including earnout, is up to £6.225 million, of which up to £4.225 million is dependent on the performance of Skore. The initial consideration is £2.0 million, payable in cash from Netcall's existing cash resources, with £1.8 million payable on completion and £0.2 million is held back and deferred for 12 months.

Up to £4.0 million of the earnout consideration is payable subject to Skore achieving contracted annualised value of software subscriptions ("Annualised Subscription Value") growth from £0.6 million to £2.0 million within three years of acquisition. The payment will be pro-rata, measured annually, and paid 50% in cash and 50% in Netcall shares with elements of both deferred until the end of the earnout period. Any Netcall shares issued will be subject to a 12 month lock-in for the management shareholders of Skore. The balance of the earnout contingent consideration is payable in cash and is dependent on achieving a minimum level of Annualised Subscription Value in the earnout period.

James Ormondroyd, CEO of Netcall plc commented: "The acquisition of Skore fits excellently within our stated acquisition rationale, bringing a highly complementary technology offering. Business process improvement is seen as an increasingly important part of the puzzle for companies wishing to improve their interactions with customers, and we believe this acquisition accelerates our position in a rapidly growing market for digital transformation and automation.

"We have a successful track record in growing our market opportunity and cross-sell potential through organic and acquisitive product expansion, and the addition of the Skore process mapping capabilities is a step forward in this journey. We look forward to welcoming the Skore team to Netcall."

For further enquiries, please contact:

 

Netcall plc

Tel. +44 (0) 330 333 6100

James Ormondroyd, CEO

 

Henrik Bang, Non-Executive Chair

 

Richard Hughes, CFO

 

 

 

Canaccord Genuity Limited (Nominated Adviser and Broker) 

Tel. +44 (0) 20 7523 8000

Simon Bridges / Andrew Potts

 

 

 

Singer Capital Markets (Joint Broker)

Tel. +44 (0) 20 7496 3000

Harry Gooden / Asha Chotai

 

 

 

Alma Strategic Communications

Tel. +44 (0) 20 3405 0205

Caroline Forde / Hilary Buchanan / Matthew Young

 

About Netcall

Netcall's Liberty software platform with Intelligent Automation and Customer Engagement solutions helps organisations digitally transform their businesses faster and more efficiently, empowering them to create a leaner, more customer-centric organisation.

Netcall's customers span enterprise, healthcare and government sectors. These include two-thirds of the NHS Acute Health Trusts and leading corporates including Legal and General, Lloyds Banking Group, Aon and Santander.

For further information, please go to www.netcall.com.

Prior to publication the information communicated in this announcement was deemed by the Company to constitute inside information for the purposes of article 7 of the Market Abuse Regulations (EU) No 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations No 2019/310 ('MAR'). With the publication of this announcement, this information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQVLLFLZFLLBBL
Date   Source Headline
22nd Apr 20247:00 amRNSNetcall launches Liberty Converse CX
16th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSExercise of Options, Director/PDMR Dealing and TVR
28th Mar 20247:58 amRNSExercise of Options and Total Voting Rights
20th Mar 20249:07 amRNS£7.6m Liberty platform Contract Renewal
6th Mar 20247:00 amRNSHalf-year Report
31st Jan 20242:05 pmRNSHolding(s) in Company
26th Jan 20243:39 pmRNSExercise of Options and Total Voting Rights
24th Jan 20242:14 pmRNSExercise of Options, PDMR Dealing & TVR
23rd Jan 20247:01 amRNSAcquisition of Skore Labs Limited
23rd Jan 20247:00 amRNSTrading Update and Notice of Results
19th Dec 202312:00 pmRNSResult of AGM
19th Dec 20237:00 amRNSAGM Statement
15th Dec 20235:31 pmRNSExercise of Options and Total Voting Rights
5th Dec 20233:53 pmRNSHolding(s) in Company
29th Nov 20233:11 pmRNSExercise of Options and Total Voting Rights
20th Nov 20234:00 pmRNSNotice of AGM and Posting of Annual Report
20th Nov 20237:00 amRNSBoard Succession & Directorate Change
11th Oct 20237:00 amRNSFinal Results for the Year Ended 30 June 2023
29th Sep 20237:00 amRNSNotice of Results and Presentations
25th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20234:44 pmRNSHolding(s) in Company
18th Aug 20239:15 amRNSExercise of Options and Total Voting Rights
20th Jul 20237:00 amRNSTrading Update and Contract Renewal
30th May 20234:49 pmRNSHolding(s) in Company
15th May 20234:10 pmRNSHolding(s) in Company
4th Apr 20234:30 pmRNSExercise of Options and Total Voting Rights
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20237:01 amRNSHalf-year Report
8th Mar 20237:00 amRNSAppointment of Joint Broker
27th Jan 20231:20 pmRNSHolding(s) in Company
24th Jan 20234:30 pmRNSExercise of Options, Director/PDMR Dealing and TVR
24th Jan 20237:00 amRNSTrading Update and Notice of Results
16th Jan 20235:35 pmRNSHolding(s) in Company
16th Jan 20235:00 pmRNSExtension of LTIP for Senior Management
20th Dec 20229:45 amRNSHolding(s) in Company
13th Dec 20226:22 pmRNSExercise of Options, Director/PDMR Dealing and TVR
8th Dec 202212:30 pmRNSResult of AGM
8th Dec 20227:00 amRNSAGM Statement
6th Dec 20225:05 pmRNSHolding(s) in Company
29th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:00 pmRNSExercise of Options and Total Voting Rights
10th Nov 20227:00 amRNSNotice of AGM and Directorate Change
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20222:00 pmRNSFinal redemption of BGF loan note
6th Oct 20222:00 pmRNSHolding(s) in Company
6th Oct 202210:30 amRNSHolding(s) in Company
5th Oct 20224:30 pmRNSHolding(s) in Company
5th Oct 20227:00 amRNSFinal Results for the Year Ended 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.